Cholesterol Med Fails to Slow Disease Progression
Treatment with simvastatin, a medication used to lower cholesterol levels, did not slow the progression of Parkinson’s disease  over…
Articles by Lindsey Shapiro, PhD
Generic Rotigotine Transdermal Patch Ready for Trial, XPhyto Says
XPhyto Therapeutics’ generic version of the Neupro patch for Parkinson’s disease is showing that its active ingredient, rotigotine, can be absorbed…
Certain Nonmotor Symptoms Predict Anxiety In Parkinson’s
REM sleep behavior disorder (RBD) and autonomic dysfunction (dysautonomia), two types of nonmotor Parkinson’s disease symptoms, were significant predictors…
LSVT-BIG Therapy as Effective Online as in Clinic for Parkinson’s
Four weeks of physical therapy — specifically, the Lee Silverman Voice Therapy (LSVT)-BIG program — given via telemedicine led to…
Repeated Smell Testing May Help ID Those at Risk for Parkinson’s
People with persistent smell deficits are more likely to develop brain imaging abnormalities suggestive of Parkinson’s disease, or be…
Study: RAGE Protein Plays Key Role in Parkinson’s Neuroinflammation
Scientists have shed new light on the interaction of toxic apha-synuclein clumps — a hallmark of Parkinson’s disease —…
GT-02287 Helps Prevent Toxic Alpha-synuclein in Patient-derived Cells
GT-02287, Gain Therapeutics’ experimental oral therapy, reduced the toxic alpha-synuclein protein clumps that characterize Parkinson’s disease in…
Combined Alpha-synuclein Test May Aid Disease Diagnosis, Monitoring
Researchers have developed a test that may help to more accurately diagnose Parkinson’s disease and monitor its progression. It…
Irisin Hormone Shows Potential as Parkinson’s Treatment
The hormone irisin prevents the buildup of toxic alpha-synuclein protein, leading to the preservation of nerve cells and easing motor…
Connectivity Changes in PPN After Exercise Tied to Motor Gains
Exercise can modify the connectivity of the brain’s pedunculopontine nucleus (PPN) with other areas of the brain in people with…